<SEC-DOCUMENT>0001140361-23-005043.txt : 20230207
<SEC-HEADER>0001140361-23-005043.hdr.sgml : 20230207
<ACCEPTANCE-DATETIME>20230207165009
ACCESSION NUMBER:		0001140361-23-005043
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20230207
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230207
DATE AS OF CHANGE:		20230207

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ROCKET PHARMACEUTICALS, INC.
		CENTRAL INDEX KEY:			0001281895
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36829
		FILM NUMBER:		23595787

	BUSINESS ADDRESS:	
		STREET 1:		350 FIFTH AVENUE
		STREET 2:		SUITE 7530
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10118
		BUSINESS PHONE:		646-440-9100

	MAIL ADDRESS:	
		STREET 1:		350 FIFTH AVENUE
		STREET 2:		SUITE 7530
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10118

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INOTEK PHARMACEUTICALS CORP
		DATE OF NAME CHANGE:	20040226
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>brhc10047551_8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:srt="http://fasb.org/srt/2022" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:naics="http://xbrl.sec.gov/naics/2022" xmlns:sic="http://xbrl.sec.gov/sic/2022" xmlns:stpr="http://xbrl.sec.gov/stpr/2022" xmlns:exch="http://xbrl.sec.gov/exch/2022" xmlns:cef="http://xbrl.sec.gov/cef/2022" xmlns:rckt="http://rocketpharma.com/20230207" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 23.1.2.5118
         Copyright 1995 - 2023 Broadridge -->
    <meta http-equiv="Content-Type" content="text/html" />
</head>

<body style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; background-color: #ffffff;">
<div id="DSPFiXBRLHidden" style="display: none;"><ix:header><ix:hidden><ix:nonNumeric name="dei:AmendmentFlag" id="Fact_1659f54584f9487d82a53db7ab8a9f3b" contextRef="c20230207to20230207" format="ixt:fixed-false">false</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" id="Fact_0f6c9cf392624bf79367a85f3adc95f5" contextRef="c20230207to20230207">0001281895</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="rckt-20230207.xsd" xlink:type="simple"></link:schemaRef></ix:references><ix:resources><xbrli:context id="c20230207to20230207"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001281895</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-02-07</xbrli:startDate><xbrli:endDate>2023-02-07</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>

  <div>
    <hr style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" />
    <div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 14pt; font-weight: bold;">UNITED STATES</div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;">Washington, DC 20549</div>

      <div style="text-align: left;"><br />
      </div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 18pt; font-weight: bold;">FORM <ix:nonNumeric name="dei:DocumentType" id="Fact_d0110c26e06942ada76d70e87f38288a" contextRef="c20230207to20230207">8-K</ix:nonNumeric></div>

      <div style="text-align: left;"><br />
      </div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">CURRENT REPORT</div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934</div>

      <div style="text-align: left;"><br />
      </div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Date of Report (Date of earliest event reported):&#160; <ix:nonNumeric name="dei:DocumentPeriodEndDate" id="Fact_2d28894c56814177aeca6c9d76c20361" contextRef="c20230207to20230207" format="ixt:date-monthname-day-year-en">February 7, 2023</ix:nonNumeric></div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br />
      </div>

      <div>
        <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;" /></div>

      <div><br /></div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 24pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityRegistrantName" id="Fact_1bfb48f3cba54eb4aedf3d7c8099c530" contextRef="c20230207to20230207">Rocket Pharmaceuticals, Inc.</ix:nonNumeric><br />
      </div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(Exact name of registrant as specified in its charter)</div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br />
      </div>

      <div>
        <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;" /></div>

      <div><br /></div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 33.3%; vertical-align: middle;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" id="Fact_1a80ad28adcc43ea88271e9c837476e5" contextRef="c20230207to20230207" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric><br />
              </div>
            </td>

    <td style="width: 34%; vertical-align: middle; text-align: center; font-weight: bold;"><ix:nonNumeric name="dei:EntityFileNumber" id="Fact_b0339850fb83470f8194e08a6d48e552" contextRef="c20230207to20230207">001-36829</ix:nonNumeric><br />
            </td>

    <td style="width: 32.7%; vertical-align: middle;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" id="Fact_0180026bc08a434da6e8eb436c3af477" contextRef="c20230207to20230207">04-3475813</ix:nonNumeric><br />
              </div>
            </td>

  </tr>

  <tr>

    <td style="width: 33.3%; vertical-align: top;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(State or other jurisdiction of incorporation)</div>
            </td>

    <td style="width: 34%; vertical-align: top;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(Commission File Number)</div>
            </td>

    <td style="width: 32.7%; vertical-align: top;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(IRS Employer Identification No.)</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <div>
        <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;" /></div>

      <div><br /></div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 49.01%; vertical-align: top;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressAddressLine1" id="Fact_d04b53fe658049869348468444c6449f" contextRef="c20230207to20230207">9 Cedarbrook Drive</ix:nonNumeric>,
                <ix:nonNumeric name="dei:EntityAddressCityOrTown" id="Fact_4e4a63932dc742a6a727ada12309a1d6" contextRef="c20230207to20230207">Cranbury</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" id="Fact_faf340c1c4c646c9946141994230a7e6" contextRef="c20230207to20230207">NJ</ix:nonNumeric></div>
            </td>

    <td style="width: 2%; vertical-align: top;">&#160;</td>

    <td style="width: 49%; vertical-align: top; text-align: center; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" id="Fact_08fe5c80da4043f3a75f7d34d6d46bf0" contextRef="c20230207to20230207">08512</ix:nonNumeric><br />
            </td>

  </tr>

  <tr>

    <td style="width: 49.01%; vertical-align: top;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">(</span>Address of principal executive offices)</div>
            </td>

    <td style="width: 2%; vertical-align: top;">&#160;</td>

    <td style="width: 49%; vertical-align: top;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(Zip Code)</div>
            </td>

  </tr>


</table>
      <div><br /></div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
        <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;" /></div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br />
      </div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Registrant&#8217;s telephone number, including area code:&#160; (<ix:nonNumeric name="dei:CityAreaCode" id="Fact_f56dc01c06f74a34a032a4fb3f11cb74" contextRef="c20230207to20230207">646</ix:nonNumeric>)
        <ix:nonNumeric name="dei:LocalPhoneNumber" id="Fact_46bf23a953aa412cb6481ac0642a8c51" contextRef="c20230207to20230207">440-9100</ix:nonNumeric></div>

      <div><br />
      </div>

      <div>
        <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;" /></div>

      <div><br /></div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Not applicable</div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(Former name or former address, if changed since last report)</div>

      <div><br />
      </div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the
        following provisions (see General Instruction A.2):</div>

      <div style="text-align: left;"><br />
      </div>

      <div style="text-align: left;">
        <div>
          <div>
            <table cellspacing="0" cellpadding="0" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;" class="DSPFListTable">


  <tr style="vertical-align: top;">

    <td style="vertical-align: top; width: 18pt;"><ix:nonNumeric name="dei:WrittenCommunications" id="Fact_9bbed170da7445bc98cf07c919fabd65" contextRef="c20230207to20230207" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
                  </td>

    <td style="align: left; vertical-align: top; width: auto;">
                    <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>
                  </td>

  </tr>


</table>
          </div>

        </div>

        <div style="text-align: left; text-indent: -27pt; margin-left: 27pt;"><br />
        </div>

        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:SolicitingMaterial" id="Fact_f96a1615a6684a74a4df2463acc5e50e" contextRef="c20230207to20230207" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric></td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>
              </td>

  </tr>


</table>
        <div style="text-align: left; text-indent: -27pt; margin-left: 27pt;"><br />
        </div>

        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementTenderOffer" id="Fact_636cc5c122bb4a89bad8f33009aefc2b" contextRef="c20230207to20230207" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric></td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</div>
              </td>

  </tr>


</table>
        <div style="text-align: left; text-indent: -27pt; margin-left: 27pt;"><br />
        </div>

        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" id="Fact_5971c6326ad34a59a648244dddf26ab6" contextRef="c20230207to20230207" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
              </td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</div>
              </td>

  </tr>


</table>
      </div>

      <div style="text-align: left;"><br />
      </div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Securities registered pursuant to Section 12(b) of the Act:</div>

      <div style="text-align: left;"><br />
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 34%; vertical-align: middle; white-space: nowrap;">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Title of each class</div>
            </td>

    <td style="width: 1%; vertical-align: middle;">&#160;</td>

    <td style="width: 30%; vertical-align: middle;">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Trading</div>
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Symbol(s)</div>
            </td>

    <td style="width: 1%; vertical-align: middle;">&#160;</td>

    <td style="width: 34%; vertical-align: middle;">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Name of each exchange on which</div>
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">registered</div>
            </td>

  </tr>

  <tr>

    <td style="width: 34%; vertical-align: middle; text-align: center;"><ix:nonNumeric name="dei:Security12bTitle" id="Fact_2e4ab53a33634fcdb9e2a5025a37c205" contextRef="c20230207to20230207">Common stock, $0.01 par value</ix:nonNumeric><br />
            </td>

    <td style="width: 1%; vertical-align: middle;">&#160;</td>

    <td style="width: 30%; vertical-align: middle;">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:TradingSymbol" id="Fact_efcba18ec4e64786a53364be13810b89" contextRef="c20230207to20230207">RCKT</ix:nonNumeric><br />
              </div>
            </td>

    <td style="width: 1%; vertical-align: middle;">&#160;</td>

    <td style="width: 34%; vertical-align: middle;">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_21a2f5cf96784714b422c502652b4550" contextRef="c20230207to20230207" format="ixt-sec:exchnameen">The Nasdaq Global Market</ix:nonNumeric><br />
              </div>
            </td>

  </tr>


</table>
      <div style="text-align: left;"><br />
      </div>

      <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167; 230.405 of this
        chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167; 240.12b-2 of this chapter).</div>

      <div style="text-align: left;"><br />
      </div>

      <div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" id="Fact_9a0ce03cd12e49b4a250177986c7de4a" contextRef="c20230207to20230207" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric></div>

      <div style="text-align: left;"><br />
      </div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new
        or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <span style="font-size: 10pt; font-family: 'Times New Roman';">&#9744;</span></div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br />
        </span></div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">
<div><span style="font-size: 10pt; font-family: 'Times New Roman';"> </span></div>

        <hr style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" /></div>

      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

      </div>

      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 54pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 8.01.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Other Events.</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">On February 7, 2023, Rocket Pharmaceuticals, Inc. (the &#8220;Company&#8221;) <span style="font-size: 10pt; font-family: 'Times New Roman';">announced that the
          U.S. Food and Drug Administration granted a Regenerative Medicine Advanced Therapy (RMAT) designation for RP-A501, its investigational gene therapy for the treatment of Danon Disease. A copy of the press release issued in connection with the
          announcement is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated into this report by reference.</span></div>

      <div><br />
      </div>

      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 54pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 9.01.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Financial Statements and Exhibits.</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <div>
        <table cellspacing="0" cellpadding="0" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;" class="DSPFListTable">


  <tr style="vertical-align: top;">

    <td style="vertical-align: top; width: 18pt;">
                <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000;">(d)</span></div>
              </td>

    <td style="align: left; vertical-align: top; width: auto;">
                <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000;">Exhibits.</span></div>
              </td>

  </tr>


</table>
      </div>

      <div><br />
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 5%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><a href="brhc10047537_ex99-1.htm">99.1</a></div>
            </td>

    <td style="width: 95%; vertical-align: top;">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Press Release of Rocket Pharmaceuticals, Inc.</div>
            </td>

  </tr>

  <tr>

    <td style="width: 5%; vertical-align: top;">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">104</div>
            </td>

    <td style="width: 95%; vertical-align: top;">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Cover Page Interactive Data File (embedded within the Inline XBRL document).</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

      </div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">SIGNATURES</div>

      <div><br />
      </div>

      <div style="text-align: left; text-indent: 20pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its
        behalf by the undersigned hereunto duly authorized.</div>

      <div><br />
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 49.91%; vertical-align: top;">&#160;</td>

    <td style="width: 50.09%; vertical-align: bottom;" colspan="2">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Rocket Pharmaceuticals, Inc.</div>
            </td>

  </tr>

  <tr>

    <td style="width: 49.91%; vertical-align: bottom;">&#160;</td>

    <td style="width: 3.21%; vertical-align: bottom;">&#160;</td>

    <td style="width: 46.88%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 49.91%; vertical-align: bottom;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Date: February 7, 2023</div>
            </td>

    <td style="width: 3.21%; vertical-align: bottom;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">By:</div>
            </td>

    <td style="width: 46.88%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">/s/ Gaurav Shah, MD</div>
            </td>

  </tr>

  <tr>

    <td style="width: 49.91%; vertical-align: top;">&#160;</td>

    <td style="width: 3.21%; vertical-align: bottom;">&#160;</td>

    <td style="width: 46.88%; vertical-align: top;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Gaurav Shah, MD</div>
            </td>

  </tr>

  <tr>

    <td style="width: 49.91%; vertical-align: top;">&#160;</td>

    <td style="width: 3.21%; vertical-align: bottom;">&#160;</td>

    <td style="width: 46.88%; vertical-align: top;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Chief Executive Officer and Director</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

    </div>

    <div><br />
    </div>

    <div>
      <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;" /></div>

  </div>

</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>brhc10047537_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 23.1.2.5118
         Copyright 1995 - 2023 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div style="text-align: right;"> <font style="font-weight: bold;">Exhibit 99.1</font><br>
    </div>
    <div style="text-align: left;"> <img src="image00002.jpg"></div>
    <div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><a name="z_Hlk92525890"></a><a name="z_Hlk63949140"></a></div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Rocket Pharmaceuticals Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for RP-A501 Gene Therapy for Danon Disease</div>
      <div><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">CRANBURY, N.J. </font>&#8211; <font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Feb. 7, 2023 </font>&#8211; Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a leading late-stage biotechnology company advancing an integrated and sustainable pipeline of genetic therapies for rare&#160; disorders with high unmet need,
        today announced that the U.S. Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT) designation to RP-A501, the Company&#8217;s investigational adeno-associated virus (AAV)-based gene therapy for the treatment of
        Danon Disease, a devastating and fatal genetic cardiac disease for which there are no disease-altering therapies available. RMAT designation was granted based on positive safety and efficacy data from the Phase 1 RP-A501 clinical trial and will
        provide the benefits of added intensive FDA guidance and expedited review through the program&#8217;s development.</div>
      <div><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;Today&#8217;s exciting RMAT designation demonstrates recognition from the FDA of the early meaningful benefit of RP-A501 in Danon Disease and its potential to deliver
        lifesaving treatment for patients,&#8221; said Gaurav Shah, M.D., Chief Executive Officer, Rocket Pharma. &#8220;We look forward to the FDA&#8217;s added guidance and support on the most efficient development and approval pathway for RP-A501, including on our
        anticipated Phase 2 pivotal trial with the opportunity for accelerated approval.&#8221;</div>
      <div><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Dr. Shah continued, &#8220;RP-A501 is the first cardiac gene therapy to receive RMAT designation from the FDA, and today&#8217;s news is another important step forward both for
        patients with Danon Disease and for the gene therapy field<font style="font-size: 10pt; font-family: 'Times New Roman';">.</font> We remain on track to initiate our Phase 2 trial in the second quarter and are thankful to the FDA for their continued
        collaboration.&#8221;</div>
      <div><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Established under the 21st Century Cures Act, RMAT designation is a dedicated program designed to expedite the drug development and review processes for promising
        pipeline products, including gene therapies. A regenerative medicine therapy is eligible for RMAT designation if it is intended to treat, modify, reverse or cure a serious or life-threatening disease or condition, and preliminary clinical evidence
        indicates that the drug or therapy has the potential to address unmet medical needs for such disease or condition.</div>
      <div><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Similar to Breakthrough Therapy designation, RMAT designation provides the benefits of intensive FDA guidance on efficient drug development, including the ability for
        early FDA interactions to discuss surrogate or intermediate endpoints, potential ways to support accelerated approval and satisfy post-approval requirements, potential priority review of the Biologics License Application (BLA) and other
        opportunities to expedite development and review. Rocket also holds Orphan Drug (U.S.) and Rare Pediatric designations for the RP-A501 program.</div>
      <div><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The initiation of the Phase 2 pivotal trial is on track for the second quarter of 2023.&#160; As previously disclosed, the Company anticipates pursuing a single arm,
        open-label trial with a biomarker-based composite endpoint and a natural history comparator.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <img src="image00002.jpg"></div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Results from the Phase 1 program represent one of the most comprehensive investigational gene therapy datasets for any cardiac condition. RP-A501 was generally well
        tolerated with evidence of restored expression of the deficient LAMP2 protein and durable improvement or stabilization of clinical parameters in the Danon Disease patients treated in the Phase 1 study.</div>
      <div><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Data show consistent and robust improvements in multiple parameters including protein expression, reduced autophagic vacuoles, brain natriuretic peptide (BNP), troponin,
        left ventricular (LV) mass and thickness, and improved New York Heart Association (NYHA) class and Kansas City Cardiomyopathy Questionnaire (KCCQ/Quality of Life) measurements. Notably, these improvements and stabilization of BNP and NYHA class are
        in stark contrast to BNP increases and NYHA class deterioration observed in a representative sample of pediatric and adolescent natural history patients. Overall, the results demonstrate improvements and/or normalization across multiple
        quantifiable parameters that cardiologists use in clinical practice to enable risk assessment and treatment decisions.</div>
      <div><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">About Danon Disease</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Danon Disease is a rare X-linked inherited disorder caused by mutations in the gene encoding lysosome-associated membrane protein 2 (LAMP-2), an important mediator of
        autophagy. This results in accumulation of autophagosomes and glycogen, particularly in cardiac muscle and other tissues, which ultimately leads to heart failure, and for male patients, frequent death during adolescence or early adulthood. It is
        estimated to have a prevalence of 15,000 to 30,000 patients in the U.S. and Europe. The only available treatment option for Danon Disease is cardiac transplantation, which is associated with substantial complications and is not considered curative.
        There are no specific therapies available for the treatment of Danon Disease.</div>
      <div><br>
      </div>
      <div>
        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">About Rocket Pharmaceuticals, Inc.</div>
        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) is advancing an integrated and sustainable pipeline of investigational genetic therapies designed to correct the root cause
          of complex and rare childhood disorders. The Company&#8217;s platform-agnostic approach enables it to design the best therapy for each indication, creating potentially transformative options for patients afflicted with rare genetic diseases. Rocket's
          clinical programs using lentiviral vector (LVV)-based gene therapy are for the treatment of Fanconi Anemia (FA), a difficult to treat genetic disease that leads to bone marrow failure and potentially cancer, Leukocyte Adhesion Deficiency-I
          (LAD-I), a severe pediatric genetic disorder that causes recurrent and life-threatening infections which are frequently fatal, and Pyruvate Kinase Deficiency (PKD), a rare, monogenic red blood cell disorder resulting in increased red cell
          destruction and mild to life-threatening anemia. Rocket&#8217;s first clinical program using adeno-associated virus (AAV)-based gene therapy is for Danon Disease, a devastating, pediatric heart failure condition. Rocket also has preclinical AAV-based
          gene therapy programs in PKP2-<font style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">a</font>rrhythmogenic cardiomyopathy<font style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> (ACM)</font> and
          BAG3-associated dilated cardiomyopathy (DCM). For more information about Rocket, please visit <u>www.rocketpharma.com<font style="font-size: 10pt; font-family: 'Times New Roman'; color: #0563C1;">.</font></u></div>
      </div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <img src="image00002.jpg"></div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Rocket Cautionary Statement Regarding Forward-Looking Statements</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Various statements in this release concerning Rocket&#8217;s future expectations, plans and prospects, including without limitation, Rocket&#8217;s expectations regarding the safety
        and effectiveness of product candidates that Rocket is developing to treat Fanconi Anemia (FA), Leukocyte Adhesion Deficiency-I (LAD-I), Pyruvate Kinase Deficiency (PKD), Danon Disease (DD) and other diseases, the expected timing and data readouts
        of Rocket&#8217;s ongoing and planned clinical trials, the expected timing and outcome of Rocket&#8217;s regulatory interactions and planned submissions, Rocket&#8217;s plans for the advancement of its Danon Disease program, including its planned pivotal trial, and
        the safety, effectiveness and timing of related pre-clinical studies and clinical trials, may constitute forward-looking statements for the purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995 and other
        federal securities laws and are subject to substantial risks, uncertainties and assumptions. You should not place reliance on these forward-looking statements, which often include words such as "believe," "expect," "anticipate," "intend," "plan,"
        "will give," "estimate," "seek," "will," "may," "suggest" or similar terms, variations of such terms or the negative of those terms. Although Rocket believes that the expectations reflected in the forward-looking statements are reasonable, Rocket
        cannot guarantee such outcomes. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including, without limitation, Rocket&#8217;s ability to monitor the impact of
        COVID-19 on its business operations and take steps to ensure the safety of patients, families and employees, the interest from patients and families for participation in each of Rocket&#8217;s ongoing trials, our expectations regarding the delays and
        impact of COVID-19 on clinical sites, patient enrollment, trial timelines and data readouts, our expectations regarding our drug supply for our ongoing and anticipated trials, actions of regulatory agencies, which may affect the initiation, timing
        and progress of pre-clinical studies and clinical trials of its product candidates, Rocket&#8217;s dependence on third parties for development, manufacture, marketing, sales and distribution of product candidates, the outcome of litigation, and
        unexpected expenditures, as well as those risks more fully discussed in the section entitled "Risk Factors" in Rocket&#8217;s Annual Report on Form 10-K for the year ended December 31, 2021, filed February 28, 2022 with the SEC and subsequent filings
        with the SEC including our Quarterly Reports on Form 10-Q.&#160; Accordingly, you should not place undue reliance on these forward-looking statements. All such statements speak only as of the date made, and Rocket undertakes no obligation to update or
        revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise.</div>
      <div><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Media</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Kevin Giordano</div>
      <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><u>kgiordano@rocketpharma.com</u></div>
      <div><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Investors</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Brooks Rahmer</div>
      <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><u>investors@rocketpharma.com</u></div>
      <div style="text-align: left;"><a name="z_Hlk122534656"></a><br>
      </div>
    </div>
    <div> <br>
    </div>
    <div>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"> </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>rckt-20230207.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 23.1.2.5118 Broadridge-->
<xs:schema targetNamespace="http://rocketpharma.com/20230207" elementFormDefault="qualified" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:rckt="http://rocketpharma.com/20230207" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="rckt-20230207_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="rckt-20230207_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://rocketpharma.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000100 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/currency/2022" schemaLocation="https://xbrl.sec.gov/currency/2022/currency-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/exch/2022" schemaLocation="https://xbrl.sec.gov/exch/2022/exch-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/naics/2022" schemaLocation="https://xbrl.sec.gov/naics/2022/naics-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/sic/2022" schemaLocation="https://xbrl.sec.gov/sic/2022/sic-2022.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/stpr/2022" schemaLocation="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd" />
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2004/ref" schemaLocation="http://www.xbrl.org/2004/ref-2004-08-10.xsd" />
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xs:import namespace="http://fasb.org/us-types/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd" />
  <xs:import namespace="http://fasb.org/srt-types/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd" />
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>rckt-20230207_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 23.1.2.5118 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:label xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CoverAbstract_lbl" xml:lang="en-US" id="dei_CoverAbstract_lbl">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:title="label: CoverAbstract to dei_CoverAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentType_lbl" xml:lang="en-US" id="dei_DocumentType_lbl">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentType" xlink:to="dei_DocumentType_lbl" xlink:title="label: DocumentType to dei_DocumentType_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:label xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_WrittenCommunications_lbl" xml:lang="en-US" id="dei_WrittenCommunications_lbl">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:title="label: WrittenCommunications to dei_WrittenCommunications_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:label xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SolicitingMaterial_lbl" xml:lang="en-US" id="dei_SolicitingMaterial_lbl">Soliciting Material</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:title="label: SolicitingMaterial to dei_SolicitingMaterial_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US" id="dei_PreCommencementTenderOffer_lbl">Pre-commencement Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:title="label: PreCommencementTenderOffer to dei_PreCommencementTenderOffer_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US" id="dei_PreCommencementIssuerTenderOffer_lbl">Pre-commencement Issuer Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:title="label: PreCommencementIssuerTenderOffer to dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:label xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_AmendmentFlag_lbl" xml:lang="en-US" id="dei_AmendmentFlag_lbl">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:title="label: AmendmentFlag to dei_AmendmentFlag_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalYearFocus_lbl">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:title="label: DocumentFiscalYearFocus to dei_DocumentFiscalYearFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalPeriodFocus_lbl">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:title="label: DocumentFiscalPeriodFocus to dei_DocumentFiscalPeriodFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US" id="dei_DocumentPeriodEndDate_lbl">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:title="label: DocumentPeriodEndDate to dei_DocumentPeriodEndDate_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:label xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityRegistrantName_lbl" xml:lang="en-US" id="dei_EntityRegistrantName_lbl">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:title="label: EntityRegistrantName to dei_EntityRegistrantName_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" id="dei_EntityCentralIndexKey_lbl">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:title="label: EntityCentralIndexKey to dei_EntityCentralIndexKey_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityFileNumber_lbl" xml:lang="en-US" id="dei_EntityFileNumber_lbl">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:title="label: EntityFileNumber to dei_EntityFileNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US" id="dei_EntityTaxIdentificationNumber_lbl">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:title="label: EntityTaxIdentificationNumber to dei_EntityTaxIdentificationNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US" id="dei_EntityIncorporationStateCountryCode_lbl">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:title="label: EntityIncorporationStateCountryCode to dei_EntityIncorporationStateCountryCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:label xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US" id="dei_EntityEmergingGrowthCompany_lbl">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:title="label: EntityEmergingGrowthCompany to dei_EntityEmergingGrowthCompany_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine1_lbl">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:title="label: EntityAddressAddressLine1 to dei_EntityAddressAddressLine1_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine2_lbl">Entity Address, Address Line Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:title="label: EntityAddressAddressLine2 to dei_EntityAddressAddressLine2_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine3_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine3_lbl">Entity Address, Address Line Three</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:title="label: EntityAddressAddressLine3 to dei_EntityAddressAddressLine3_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US" id="dei_EntityAddressCityOrTown_lbl">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:title="label: EntityAddressCityOrTown to dei_EntityAddressCityOrTown_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US" id="dei_EntityAddressStateOrProvince_lbl">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:title="label: EntityAddressStateOrProvince to dei_EntityAddressStateOrProvince_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCountry_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCountry_lbl" xml:lang="en-US" id="dei_EntityAddressCountry_lbl">Entity Address, Country</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:title="label: EntityAddressCountry to dei_EntityAddressCountry_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US" id="dei_EntityAddressPostalZipCode_lbl">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:title="label: EntityAddressPostalZipCode to dei_EntityAddressPostalZipCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:label xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CityAreaCode_lbl" xml:lang="en-US" id="dei_CityAreaCode_lbl">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:title="label: CityAreaCode to dei_CityAreaCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:label xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_LocalPhoneNumber_lbl" xml:lang="en-US" id="dei_LocalPhoneNumber_lbl">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:title="label: LocalPhoneNumber to dei_LocalPhoneNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:label xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_Security12bTitle_lbl" xml:lang="en-US" id="dei_Security12bTitle_lbl">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:title="label: Security12bTitle to dei_Security12bTitle_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:label xlink:type="resource" xlink:label="dei_NoTradingSymbolFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US" id="dei_NoTradingSymbolFlag_lbl">No Trading Symbol Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:title="label: NoTradingSymbolFlag to dei_NoTradingSymbolFlag_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:label xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_TradingSymbol_lbl" xml:lang="en-US" id="dei_TradingSymbol_lbl">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:title="label: TradingSymbol to dei_TradingSymbol_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:label xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SecurityExchangeName_lbl" xml:lang="en-US" id="dei_SecurityExchangeName_lbl">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:title="label: SecurityExchangeName to dei_SecurityExchangeName_lbl" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>rckt-20230207_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 23.1.2.5118 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:roleRef roleURI="http://rocketpharma.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="rckt-20230207.xsd#DocumentAndEntityInformation" />
  <link:presentationLink xlink:type="extended" xlink:role="http://rocketpharma.com/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentType" xlink:title="presentation: CoverAbstract to DocumentType" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="AmendmentFlag" xlink:title="presentation: CoverAbstract to AmendmentFlag" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentPeriodEndDate" xlink:title="presentation: CoverAbstract to DocumentPeriodEndDate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalYearFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalYearFocus" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalPeriodFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalPeriodFocus" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityFileNumber" xlink:title="presentation: CoverAbstract to EntityFileNumber" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityRegistrantName" xlink:title="presentation: CoverAbstract to EntityRegistrantName" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityCentralIndexKey" xlink:title="presentation: CoverAbstract to EntityCentralIndexKey" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityIncorporationStateCountryCode" xlink:title="presentation: CoverAbstract to EntityIncorporationStateCountryCode" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityTaxIdentificationNumber" xlink:title="presentation: CoverAbstract to EntityTaxIdentificationNumber" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine1" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine1" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine2" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine2" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine3" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine3" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCityOrTown" xlink:title="presentation: CoverAbstract to EntityAddressCityOrTown" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressStateOrProvince" xlink:title="presentation: CoverAbstract to EntityAddressStateOrProvince" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCountry" xlink:title="presentation: CoverAbstract to EntityAddressCountry" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressPostalZipCode" xlink:title="presentation: CoverAbstract to EntityAddressPostalZipCode" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="CityAreaCode" xlink:title="presentation: CoverAbstract to CityAreaCode" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="LocalPhoneNumber" xlink:title="presentation: CoverAbstract to LocalPhoneNumber" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="Security12bTitle" xlink:title="presentation: CoverAbstract to Security12bTitle" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="TradingSymbol" xlink:title="presentation: CoverAbstract to TradingSymbol" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="NoTradingSymbolFlag" xlink:title="presentation: CoverAbstract to NoTradingSymbolFlag" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SecurityExchangeName" xlink:title="presentation: CoverAbstract to SecurityExchangeName" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityEmergingGrowthCompany" xlink:title="presentation: CoverAbstract to EntityEmergingGrowthCompany" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="WrittenCommunications" xlink:title="presentation: CoverAbstract to WrittenCommunications" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SolicitingMaterial" xlink:title="presentation: CoverAbstract to SolicitingMaterial" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementTenderOffer" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementIssuerTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementIssuerTenderOffer" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image00002.jpg
<TEXT>
begin 644 image00002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" !2 +X# 2(  A$! Q$!_\0
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M/J!_C4$VLA]QUC/TR/84[)JR9"E*,G.4=';^FO\ *YSU==\)?^2B:-_UT?\
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? "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140093536814768">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Feb. 07, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Feb.  07,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-36829<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Rocket Pharmaceuticals, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001281895<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">04-3475813<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">9 Cedarbrook Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Cranbury<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NJ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">08512<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">646<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">440-9100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, $0.01 par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">RCKT<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>brhc10047551_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="rckt-20230207.xsd" xlink:type="simple"/>
    <context id="c20230207to20230207">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001281895</identifier>
        </entity>
        <period>
            <startDate>2023-02-07</startDate>
            <endDate>2023-02-07</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="c20230207to20230207"
      id="Fact_1659f54584f9487d82a53db7ab8a9f3b">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="c20230207to20230207"
      id="Fact_0f6c9cf392624bf79367a85f3adc95f5">0001281895</dei:EntityCentralIndexKey>
    <dei:DocumentType
      contextRef="c20230207to20230207"
      id="Fact_d0110c26e06942ada76d70e87f38288a">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="c20230207to20230207"
      id="Fact_2d28894c56814177aeca6c9d76c20361">2023-02-07</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="c20230207to20230207"
      id="Fact_1bfb48f3cba54eb4aedf3d7c8099c530">Rocket Pharmaceuticals, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="c20230207to20230207"
      id="Fact_1a80ad28adcc43ea88271e9c837476e5">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="c20230207to20230207"
      id="Fact_b0339850fb83470f8194e08a6d48e552">001-36829</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="c20230207to20230207"
      id="Fact_0180026bc08a434da6e8eb436c3af477">04-3475813</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="c20230207to20230207"
      id="Fact_d04b53fe658049869348468444c6449f">9 Cedarbrook Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="c20230207to20230207"
      id="Fact_4e4a63932dc742a6a727ada12309a1d6">Cranbury</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="c20230207to20230207"
      id="Fact_faf340c1c4c646c9946141994230a7e6">NJ</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="c20230207to20230207"
      id="Fact_08fe5c80da4043f3a75f7d34d6d46bf0">08512</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="c20230207to20230207"
      id="Fact_f56dc01c06f74a34a032a4fb3f11cb74">646</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="c20230207to20230207"
      id="Fact_46bf23a953aa412cb6481ac0642a8c51">440-9100</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="c20230207to20230207"
      id="Fact_9bbed170da7445bc98cf07c919fabd65">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="c20230207to20230207"
      id="Fact_f96a1615a6684a74a4df2463acc5e50e">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="c20230207to20230207"
      id="Fact_636cc5c122bb4a89bad8f33009aefc2b">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="c20230207to20230207"
      id="Fact_5971c6326ad34a59a648244dddf26ab6">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="c20230207to20230207"
      id="Fact_2e4ab53a33634fcdb9e2a5025a37c205">Common stock, $0.01 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="c20230207to20230207"
      id="Fact_efcba18ec4e64786a53364be13810b89">RCKT</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="c20230207to20230207"
      id="Fact_21a2f5cf96784714b422c502652b4550">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="c20230207to20230207"
      id="Fact_9a0ce03cd12e49b4a250177986c7de4a">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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M>ZC+N.HL?X;[:)'-M[#/)73)>UYN1]76^T$D7O!9QP<<GB-WPQ-',)^ Q1'
ML#P8 \PG>&%Y_J?]K-#]! SCMHHB*]1GA?H$KQBR'3Y8GKA/[I_X3O,\3;,,
MJ^AV&V6PQ>J69? 7CX9Q P\L#V1Z6ZWQ;N,3\OH<8#U];4*PG>*3B.T4KS4@
M\;J!1Y['NXWE 0^L"]CL0/YX'IBIN$^:0E<Q;M@)QI$\QQ"8Q?B,9AE2G0P^
M\?Y@IR1-\SR. !9GD*88 J<11S &P %#TG1X#SY['R73>RHY_U=3_ 102P,$
M%     @ 0X9'5I>*NQS     $P(   L   !?<F5L<R\N<F5L<YV2N6[#, Q
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M2P$"% ,4    " !#AD=677@H".T    K @  $0              @ &O
M9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    " !#AD=6F5R<(Q &  "<)P
M$P              @ '+ 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0
M   ( $.&1U:[A4O-5@0  ),0   8              " @0P(  !X;"]W;W)K
M<VAE971S+W-H965T,2YX;6Q02P$"% ,4    " !#AD=6GZ ;\+$"  #B#
M#0              @ &8#   >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( $.&
M1U:7BKL<P    !,"   +              "  70/  !?<F5L<R\N<F5L<U!+
M 0(4 Q0    ( $.&1U8<.&7J/P$  #P"   /              "  5T0  !X
M;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " !#AD=6)!Z;HJT   #X 0  &@
M            @ ')$0  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"
M% ,4    " !#AD=699!YDAD!  #/ P  $P              @ &N$@  6T-O
F;G1E;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"  #X$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="brhc10047551_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000100 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rocketpharma.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="brhc10047551_8k.htm">brhc10047551_8k.htm</File>
    <File>brhc10047537_ex99-1.htm</File>
    <File>rckt-20230207.xsd</File>
    <File>rckt-20230207_lab.xml</File>
    <File>rckt-20230207_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "brhc10047551_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2022": 22
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "brhc10047551_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "rckt-20230207_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "rckt-20230207_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "rckt-20230207.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2004/ref-2004-08-10.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/currency/2022/currency-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/exch/2022/exch-2022.xsd",
      "https://xbrl.sec.gov/naics/2022/naics-2022.xsd",
      "https://xbrl.sec.gov/sic/2022/sic-2022.xsd",
      "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd"
     ]
    }
   },
   "elementCount": 29,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "rckt",
   "nsuri": "http://rocketpharma.com/20230207",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10047551_8k.htm",
      "contextRef": "c20230207to20230207",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000100 - Document - Document and Entity Information",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://rocketpharma.com/role/DocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10047551_8k.htm",
      "contextRef": "c20230207to20230207",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001140361-23-005043-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001140361-23-005043-xbrl.zip
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MW=;8#E2BSN#[E:L+636AF/2J(C#U=N<P[MJY(]M2LDQ)12R/O'7P0F4:'ZJ
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M>>@6G^"@@Q.%[VG0M30JI4<#XQ)C.&%>[B(-4K<*4;3C#(*J9$H/>H_[_:/
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M,# T-S4U,5\X:RYH=&WM76U3XSJR_GZK[G_0Y=S=A2J<^$5^"PQ53(!9]LP
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M&X97>[^;#L<BNNWG""BTD8;D6.JO:UI%T(#G!,F1:?R/473W::>;)CETK=W
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M<IYJ;VZ2=P_;LLVC<C8EWAH*D)1H2&+$'S@=Y: FX#'8:9ZM"TK>8GUO#]V
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MBB?MO-^#8*;7AVWYO[>.U+_CR@<Q7/P'4$L#!!0    ( $.&1U;Z!I<'2@,
M $4/   1    <F-K="TR,#(S,#(P-RYX<V2U5]]OTS 0?D?B?S!YS\]NL%;K
M)M V-&DP-$#B#;G.M;7FVL%V:?O?8SMQFZ9K:1IXLWW????=^>PXE]?+&4._
M02HJ^#!(HR1 P(G(*9\,@[D*L2*4!M=7KU]=O@G#C\!!8@TY&JW0!REP+FD^
M ?3EZ7%,&:"L%Z51%IVGZ47-'(;6?:D&BDQAAI'&<@+Z,YZ!*C"!83#5NAC$
ML13D&70QQ7*&(R)F<99DO21+WAE-#&; ]9V0LQL8XSG3P^#7'#,ZII 'R"3!
MU6"IUE2+Q2):]"(A)X8D2>,?GQZ^NN >*\FS/B9PB6:4/V]Q+T>2>?9>;,TC
MK& M9 =?:4G[_7[LK&NH(:('J"E7&G,"=7R^45X'G\>ET4/-[NE5 9NBC+$:
M.;"WV#PS#U=2[\.O35L..=!M'0I(-!&_8V/8!FK98-[*TYAC:[8^29BD898&
MIF$0LBV#.1<::].=;JE:+ K*QZ):,6NVH@._"T\P1J[& \LZ#!2=%<P6T*U-
M)8R'@=W^T._RST)"9*1ZB!0,#FR)-<?&19F&=,H>-H$]!99DAV6G!PR)*$!J
M:@J[::'XGZ7%\*AM6L8%V/_-Q_)\,QD@._C^=+__%#I%-X+,[=%_S_-;KJE>
MW9N=-PA;^ #1?!@<1*R#^_ YC"FGKJ$2<S,D"0J19Z@/,<]128=J?)=QDZ3)
M/U>0/_(K-VXV2>5=00YY$LS(G)W@N%&VWZ]:]1OA#U;<.%GEPO;YLZ?/])V0
M&O&=^[M^OTPP+JI+H+SU'P1Q-"5:^3OC19\8F%9^Q?9S%BU5[EOIH(8]%]%!
M#4VX'72(2L2<:[EJ$[GNXB==%,RE-%_Q=A+J/NM9!Q&P)-,V M9X-^H0F&-*
M5)O(&X=RV"&VHJ1-9 ^W@W91F_=WO[PM.4SL\^SE\$TW)N665VAYPC0+T[?=
M=>C6&O0I\;?+J0O9JOP>[T;=-J#^5#LF<>=B9Z'WL^GW;/J]]&059[&T'^TC
M!3BT#7L6)A=AFK2K^LZS\\BHWL$&/C\ZY+[':X>OBZ/I>NRJEY'11W0(RX)A
MCK60JSLS/_X(U%EN-R2GG(CZJ[U5C3R^K(]]\[<JS=Z_A5.C=]V>E_XK]HKY
MFZ>;JXT0]S@JR:[^ %!+ P04    " !#AD=6D((4-GX(  !T6   %0   ')C
M:W0M,C R,S R,#=?;&%B+GAM;,V<76_;-A2&[P?L/W#>S0;4=BUCPQ(T+K(L
M*8*E29"DV!>&0I9I1Y@L!I3<./]^I"3:(GE(*14EZZ9U>-[S\NLYDJQ$>O=^
MNX[0%TR3D,0G@\GH[0#A.""+,%Z=##;)T$^",!R\GWW[S;OOAL,/.,;43_$"
MS5_0KY3X"QHN5AC=WMTLPP@C;SJ:C+S13Y/)+Z7P<,C3HS#^[YC_,_<3C%BW
M<7*\3<*3P6.:/AV/Q\_/SZ/GZ8C0U=A[^W8R_O/CU7WPB-?^,(R3U(\#/$!,
M?YQDC5<D\--LS*7T[9Q&PF ZWO5E5/"?AD(VY$W#B3><3D;;9#$HALC#-3H1
M\JVF+^8T.3HZ&F?1G909A1;KW;39ZB&4KQ\E$;[#2\3__W1W:<P^&G/%.,;I
ME3_'$>LR2T]?GO#)( G73Q$6;8\4+V&?B-*=#5^=([XZDY_YZGR_=QXW&=Z*
MP_1 4C]R,\[,3Q^KUDWS05^[6EK;D*]=KC(K<MS!*I>Z:3[H6TQ#LCB/%^T/
M7.W*U>#O4Y]V@(K>6?,)M#]J8*@1;[IBGZ1^\3;%\0(O1,_<VW+LS+K.#K:9
M\\Z;!))KQ,\BA.K329AKYIC@8+0B7\8+'#)GS^,?AOQ#-@OVP^<SPDZ?I_,D
MI7Z0"J=L$B<#,):&*1^[$AO+ ^7YTE I3LB&!ECI01O!YV@>O6J1I#W.AV8R
M74>L6WYA@./AI_L!"A<F[2QK0O^(QG_?C?>CUF=Z2N5]\6D@AL0^5DRC4(P#
MPDZ63^E0FM&2DK5I'TC%\A6KD?D=(TF&4H(,N>/6B?N-!)LUCM,'YJC@ (6*
M:<BA!KB5C5S1!GB:8-.D,]&">--A00/7G]C73<:LK!*4Z9GM0_8'#5-VR#TC
MZ_4F#O.+[42AP:HIIF70-. /='0%HLW<1*0Y9U:$D!P[+*/V72,U%UFF%I0+
M?"U>[7-\3Z(P"%/V??8CN^"@H1\I2)D%Q10A00-\=3M7[!J=3> :$F;[=B0"
MAT76LD>DSJK*L.I:0:K)I7U,;RGF]8'9$F1'>GZQ2V^62TP5A*J%Q61MP@;X
MFFU=85S9@PGGBL09BP^#D@#E"I1)#@MXC5TEKUE_&7ASC@"_RK7S KA,D@VF
MM<O *(>+ 9"[*PG-O*7",/53LSS@=+U(<EU_:\6\]7#%6+?'6C=:IJ%Z##VT
M7T.GK/<%'\%%Y*\44,%8,5TEUJ 4)"=7W$.F)LAU[6S7A'C;8=F%=X%4+)Y,
MI203" *YW=V(N B3P(_^PCZ]8"WJM\0*E7)[0E,YN%.A>+J^:0';5]V_@++V
MMS+R*.)AE,7[<5_#M(>D]H+#=SN4!/7&!^C7-=_Y'?9JP@$=R+BD<T9YR;4=
MSO4.ZI&NYFFLYX+^T0[M)\B[8>EMQ)=28.8US^ZHW_U"[#?V7=A /*A1:%<T
M#DB7'%U3#IE7$:[G[.DNL&9!Q*/](!O>-U)SF6&B);E*,^#5/LGG,1OIRQU>
MA?P7-'%Z[:]5K&R28IJPI '&D*$KBBW>)HB-*;,\@O8AQ&.')=BZ8:3> LO\
M0FJ!K]FI*WK/6/%0/[ID7R:WO^,7$%^#1N)7TS0&6'%T2S!L;D<8RA$,%S&4
M!1&+]H%BT[Z1FLL,<:S(99!!KZY(O@@C?+U9S[5[>::PQ&\YW!C=O9E;:C5?
M.["*7+#*FU'>W@=*@8TAU8L)L;E7REBJ#ET1^>!O+Q>L),)E\5M)"YX56HE5
MH[8QN 9GMQ3;.[$C;<L5?#,-DD4]HKUJG\DKMP.J T.:7!16[ZXJY#(."'TB
M-!O ?<JNW<_(AIU#7L[( KZ4KI4A54M%1N.:L?J[K9PZ7=GKI]I!5)&D?(,R
M+2(4%7K$$_I04/6 (%^U8U!Q69/E$JO13U>%=K[&=!7&JP^4/*>/9V3]Y,?P
MQ;Y5*1660=FXH$!?MX5DZ\)>0.9,43A"@7()*C1]J!7[WI)7;0)4&V"27!,6
MWZYJX72Q8 PFQ7]788PG8"58=%(=@+K&50"XNJT!<P?V"C#E"?Z+P!OQ 7$)
MNHE[<;:P[2EYQ?)#] ,I,OM&S\.1[]4DWZM)OM<*^5[;Y'M?2;Y7@_R'9])/
M\KVZY'NO)]^K(M\[-/G3FN1/:Y(_;87\:=OD3[^2_&D=\MF&]?2H/ZW+_O3U
M[$^KV)\>A/TS]O&&/I#GV$:^KH*X+ZM<4;_W;(5YS;X6\4J6QCN/\V_%7-$C
MTH%=A#B'E]Q"^3X!9%SUZYCP["OV#;VEY$L8:\#5D4*L:U)7P"O&K5 /]U$+
M?2A5XW]W6TC(>E0$ICV&*L&R%Y9R4++ F@"=NS[TY[>=K,=]60(>](7$V1$_
M-VSG<"]YUSO6EU+T WT>[!'>ZHZ!!WA]A6U']^+6+GAH+SMUC.\M25(_^CM\
M,OY6P":$4%:$KH"6;%O!&NJA%MQZHH9X+D%,TYN;^]9]A8 W[H %>RD'A!]P
M;;\$^,74*<4^ #T4*B8HAYJ\]:%DY.RE#[JG\9T/JG2676KSIA[0"6X L2^<
M3&!9M7O;@Y;9/F7\15?1[2.)X;^=,86+R>CA!L2I9JZH,_B:R /ELZP59<V]
M^&L"X\:0ZL642525@D;8H8,GZG&PH:P2)M[\@0]4(<44+B:EAYL\2Z^8.7N2
M'O8U/D</R6?91T26:.+],/\1"=&!GZ0W[0ZI7E$92U6Y>X8>=&@?RVOR0'W^
MWL+[E_6<1, CD!9%,350T8!/P,\5HF9K$Z6FC-DU044$Y:$>/"AIVRM2:W%E
M6@&Q -;HTSZS4L<*/V"LF)02:T"HY.2*3<C41*6NG<DP'I9#>!=(Q>+)[$DR
M01V0V]VI^WP;/++-P, #,3:)<@J7)0Y.XV5#UZ=RP+OJ=*ZES$0$B5 /'HBQ
M;ABIM\#PF;VL5L_NNE/Q#L?26ERQ3_S-OT53F+\I=_8_4$L#!!0    ( $.&
M1U;H^_(RX 4  /D^   5    <F-K="TR,#(S,#(P-U]P<F4N>&ULU5M;;^(X
M%'Y?:?]#EGV&E+!SH6IGU.VTHVJ9%A56>WE9F<2 U21&3FCAWZ\=[!8[MA.F
M[>CTA4O.Y^/S^?MR.X23SYLL#>XQ*PC-3SO]WE$GP'E,$Y(O3COKHHN*F)#.
MYT\__W3R2[?[%>>8H1(GP6P;_,XH2AA)%C@8W][,28J#:-#K]Z+>NW[_XUZX
MVQ7#4Y+?'8N7&2IPP*?-B^--04X[R[)<'8?AP\-#[V'0HVP11D='_?#O;Z-)
MO,09ZI*\*%$>XT[ \<=%M7%$8U16->\-W\Q8JA(,PL>YG CQK:M@7;&IVX^Z
M@WYO4R0=6:((MYA$P3<UO.34'PZ'815]A/)$Q)/ZD39?O2#8K1^C*;[%\T"\
M_WE[Y1P]# 4BS'$Y0C.<\BFKX>5VA4\[!<E6*5;;E@S/[7E2QA[3B-49BM7I
MOQ>K\^M3YO YY2V$F::T1.G+U%GEJ]=:F^;Y15^_U-+Z2KY^R57F.SG^ :N\
M-\WSBQYC1FARD2>O7[@YU4L5/RD1^P%6J4_V? *O7_4!I3(:W^%RM40L0[V8
M9KOT7VB\SG!>GN5<NI*4VZM\3CE"G!N:*V?QG3BR18.CZ.A#59<_WWZ=*X8+
M#JPB([Y!FPQO2IPG.%'3B5J?PZ2:5\V<TEB;+!7G0LKJHA1\LDJ1 L>]!;T/
M$TRXRE$D/@C>4<69?_GOG/*+@+-943(4ERI3*M0Y[5ACO$)!R8B%KUZH6J8I
MSVC4:0O),O607N6^D&=,KQBQ6&7B'S45ZR=LB0A7B/%\W7A)TD<#S!G-7"M)
MO:7OEW<<:!F"D@;Z2,H2S$X[1^(ZC@^<8\;D3N:INRHZW=\37U/ ,UYM(BJ^
M3-'"4- :D^M@Q.!IZ"N^041CJ%2Q#UA%9;O'L^87?CAW[(]6C+%C&AAXZK8A
MTW)7-5)(M:,WH/8E*6*4_H,1N^1;"H?>#I2A> T%5W,_H9:JUY)(W0=O1O>=
M;YN5M^"LVFLXZ.J[21VDOY9&.N WP [878I>DA1?K[,99H;PKK!<FGH8GLP-
M%!K4K8^6HKX#+^HM7A!!)"^O46:>NWT035P3 E5@+Y56(IL9I-#OP0M]SJDQ
ME%[Q&]+-'WAK5=J!T:2N8:!J[2?32NQ:"JGV!_!J7^4Q92O**GX33A.?TS4G
MLSVGB7TO;S5"<T+#"*B^.(1H*Y<T))2>^0C>,U.TN4HX6S(GNY]5/"?[!JSF
M$R<6JD/:D6OE#6<JZ8HA>%><)0DG6LBW$<EQW^H(#TYS@Q4'U0G-I%JYP)I&
M]7<@M^E<Y4<M+1"UM$#TEBQ@DOI."T1/%H#<XW.5/VAI@4%+"PS>D@5,4M]I
M@<&3!2 W_K3RS_G'&S:E#[G/ '643?Y]%'#QG80.D7X_B1(><N=/*[ZZLKUA
M8T;OR>XY'*?Z#JC- C4H<!_XJ1UBAEHFY0CXG4!EY]UMCO<XH$.L!P$% :Z\
MG<I!N[_*H)2&WQZ4E8]I4:+T7[)RM@]\0)OJ!A"X]CY:ASC R*-\ +E[*,Y9
M9PPCB_*VD'HB1 O!4]=3>H.>^DBE(.2.H'A*-ATO:6[_]<85ELM1#\-3LX%"
M@Z+UT4I5R#V["8[7C'NQ'\VF@J:AJBLLEZ0>AJ=J X4&5>NCE:J0>VY3AL13
M]Y-M-J.I(:DU)A?#B,$3TU=\@Y+&4/6D#.2^V375BK8\Y.9!R%6Q(N )VTRD
M05YK B4RY,Z8.L)<;.(ERA?8\@.Z#V(<B74(/)U;4&EY1-8S**7A-\ N,LP6
MW*=?&7THE^<T6Z'<?O/K16IW0PXD//G;$VMU/^1(I,P N2GV%_=PB7-><[;.
MY:]ZYJ-P7HQ<)P<&GO1MR#2([DBAY(;<\9K0E,2DY%[]ADK,"#(OR]P =82W
M ."IW$BCZ>AN&:_TA=SG&C,L;(GS&%?_H!#_V&$W\WGM/KD9*!?*!X2G>VM:
M#?K[\B@?0.YS&?5?%<4:L]9N<,+MGK# P3NCB>)A_K!D4RYY;B_M)*PMX8AO
M$'\_WT7$B_B[]J?_ 5!+ 0(4 Q0    ( $.&1U:D@0]$I!(  $<\   7
M          "  0    !B<FAC,3 P-#<U,S=?97@Y.2TQ+FAT;5!+ 0(4 Q0
M   ( $.&1U9G%XF$)1(  ,YP   3              "  =D2  !B<FAC,3 P
M-#<U-3%?.&LN:'1M4$L! A0#%     @ 0X9'5OH&EP=* P  10\  !$
M         ( !+R4  ')C:W0M,C R,S R,#<N>'-D4$L! A0#%     @ 0X9'
M5I""%#9^"   =%@  !4              ( !J"@  ')C:W0M,C R,S R,#=?
M;&%B+GAM;%!+ 0(4 Q0    ( $.&1U;H^_(RX 4  /D^   5
M  "  5DQ  !R8VMT+3(P,C,P,C W7W!R92YX;6Q02P4&      4 !0!+ 0
&;#<

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
